- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 560817, 13 pages
New Insights into the Immunological Changes in IL-10-Deficient Mice during the Course of Spontaneous Inflammation in the Gut Mucosa
1Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, 31270-901 Belo Horizonte, MG, Brazil
2Departamento de Ciência de Alimentos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
3Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
4Gastrointestinal Research Group, Department of Physiology and Pharmacology, University of Calgary, 2500 University Dr. NW T2N 4N1, Calgary, AB, Canada
Received 16 May 2011; Accepted 15 October 2011
Academic Editor: Noriko Tsuji
Copyright © 2012 Ana Cristina Gomes-Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. Mayer, “Mucosal immunity,” Immunological Reviews, vol. 206, p. 5, 2005.
- P. Brandtzaeg, “Development and basic mechanisms of human gut immunity,” Nutrition Reviews, vol. 56, no. 1, pp. S5–S18, 1998.
- S. R. Gill, M. Pop, R. T. DeBoy et al., “Metagenomic analysis of the human distal gut microbiome,” Science, vol. 312, no. 5778, pp. 1355–1359, 2006.
- J. S. Menezes, D. S. Mucida, D. C. Cara et al., “Stimulation by food proteins plays a critical role in the maturation of the immune system,” International Immunology, vol. 15, no. 3, pp. 447–455, 2003.
- H. A. Gordon and L. Pesti, “The gnotobiotic animal as a tool in the study of host microbial relationships,” Bacteriological Reviews, vol. 35, no. 4, pp. 390–429, 1971.
- A. M. Faria and H. L. Weiner, “Oral tolerance,” Immunological Reviews, vol. 206, pp. 232–259, 2005.
- N. M. Vaz, M. J. Rios, L. M. Lopes et al., “Genetics of susceptibility to oral tolerance to ovalbumin,” The Brazilian Journal of Medical and Biological Research, vol. 20, no. 6, pp. 785–790, 1987.
- W. Strober, I. J. Fuss, and R. S. Blumberg, “The immunology of mucosal models of inflammation,” Annual Review of Immunology, vol. 20, pp. 495–549, 2002.
- R. B. Sartor, “Pathogenesis and immune mechanisms of chronic Inflammatory Bowel Diseases,” The American Journal of Gastroenterology, vol. 92, no. 12, supplement, pp. 5S–11S, 1997.
- R. Duchmann, I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K. H. Meyer Zum Buschenfelde, “Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD),” Clinical and Experimental Immunology, vol. 102, no. 3, pp. 448–455, 1995.
- F. Powrie, M. W. Leach, S. Mauze, L. B. Caddle, and R. L. Coffman, “Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice,” International Immunology, vol. 5, no. 11, pp. 1461–1471, 1993.
- C. Asseman, S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie, “An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation,” Journal of Experimental Medicine, vol. 190, no. 7, pp. 995–1004, 1999.
- M. J. Skeen, M. A. Miller, T. M. Shinnick, and H. Kirk Ziegler, “Regulation of murine macrophage IL-12 production: activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines,” Journal of Immunology, vol. 156, no. 3, pp. 1196–1206, 1996.
- K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001.
- R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller, “Interleukin-10-deficient mice develop chronic enterocolitis,” Cell, vol. 75, no. 2, pp. 263–274, 1993.
- R. K. Sellon, S. Tonkonogy, M. Schultz et al., “Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice,” Infection and Immunity, vol. 66, no. 11, pp. 5224–5231, 1998.
- N. J. Davidson, M. W. Leach, M. M. Fort et al., “T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice,” Journal of Experimental Medicine, vol. 184, no. 1, pp. 241–251, 1996.
- S. Kawachi, S. Jennings, J. Panes et al., “Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice,” The American Journal of Physiology, vol. 278, no. 5, pp. G734–G743, 2000.
- D. J. Berg, N. Davidson, R. Kuhn et al., “Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ Th1-like responses,” Journal of Clinical Investigation, vol. 98, no. 4, pp. 1010–1020, 1996.
- D. K. Podolsky, “Inflammatory bowel disease (1),” The New England Journal of Medicine, vol. 325, pp. 928–937, 1991.
- L. Ohman, L. Franzen, U. Rudolph, G. R. Harriman, and H. E. Hultgren, “Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice,” Scandinavian Journal of Immunology, vol. 52, no. 1, pp. 80–90, 2000.
- T. M. Kundig, H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak, “Immune responses in interleukin-2-deficient mice,” Science, vol. 262, no. 5136, pp. 1059–1061, 1993.
- D. M. McCafferty, E. Sihota, M. Muscara, J. L. Wallace, K. A. Sharkey, and P. Kubes, “Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice,” The American Journal of Physiology, vol. 279, no. 1, pp. G90–G99, 2000.
- M. D. J. Davies and D. M. Parrott, “Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine,” Gut, vol. 22, no. 6, pp. 481–488, 1981.
- F. Lambolez, M. Kronenberg, and H. Cheroutre, “Thymic differentiation of TCRαβ+ CD8αα + IELs,” Immunological Reviews, vol. 215, no. 1, pp. 178–188, 2007.
- M. Mahler and E. H. Leiter, “Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice,” Inflammatory Bowel Diseases, vol. 8, no. 5, pp. 347–355, 2002.
- A. Ramachandran, M. Madesh, and K. A. Balasubramanian, “Apoptosis in the intestinal epithelium: its relevance in normal and pathophysiological conditions,” Journal of Gastroenterology and Hepatology, vol. 15, no. 2, pp. 109–120, 2000.
- J. A. Kapp, L. M. Kapp, K. C. Mckenna, and J. P. Lake, “γδ T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo,” Immunology, vol. 111, no. 2, pp. 155–164, 2004.
- Y. Ke, K. Pearce, J. P. Lake, H. K. Ziegler, and J. A. Kapp, “Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance,” Journal of Immunology, vol. 158, no. 8, pp. 3610–3618, 1997.
- Y. Chen, K. Chou, E. Fuchs, W. L. Havran, and R. Boismenu, “Protection of the intestinal mucosa by intraepithelial γδ T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 14338–14343, 2002.
- A. F. Santiago, A. C. Alves, R. P. Oliveira, et al., “Aging correlates with reduction in regulatory-type cytokines and T cells in the gut mucosa,” Immunobiology, vol. 216, no. 10, pp. 1085–1093, 2011.
- N. J. Davidson, S. A. Hudak, R. E. Lesley, S. Menon, M. W. Leach, and D. M. Rennick, “IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice,” Journal of Immunology, vol. 161, no. 6, pp. 3143–3149, 1998.
- D. Yen, J. Cheung, H. Scheerens et al., “IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1310–1316, 2006.
- T. Feng, H. Qin, L. Wang, E. N. Benveniste, C. O. Elson, and Y. Cong, “Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production,” Journal of Immunology, vol. 186, no. 11, pp. 6313–6318, 2011.
- Y. Mikami, T. Kanai, T. Sujino et al., “Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis,” European Journal of Immunology, vol. 40, no. 9, pp. 2409–2422, 2010.
- D. M. Mosser, “The many faces of macrophage activation,” Journal of Leukocyte Biology, vol. 73, no. 2, pp. 209–212, 2003.
- A. Izcue, J. L. Coombes, and F. Powrie, “Regulatory lymphocytes and intestinal inflammation,” Annual Review of Immunology, vol. 27, pp. 313–338, 2009.
- M. Murai, O. Turovskaya, G. Kim et al., “Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis,” Nature Immunology, vol. 10, no. 11, pp. 1178–1184, 2009.
- K. Nakamura, A. Kitani, I. Fuss et al., “TGF-β1 plays an important role in the mechanism of CD4 +CD25+ regulatory T cell activity in both humans and mice,” Journal of Immunology, vol. 172, no. 2, pp. 834–842, 2004.
- R. Gandhi, M. F. Farez, Y. Wang, D. Kozoriz, F. J. Quintana, and H. L. Weiner, “Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset,” Journal of Immunology, vol. 184, no. 9, pp. 4620–4624, 2010.
- B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak, “Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene,” Cell, vol. 75, no. 2, pp. 253–261, 1993.
- L. S. Berberian, Y. Valles-Ayoub, L. K. Gordon, S. R. Targan, and J. Braun, “Expression of a novel autoantibody defined by the V(H)3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis,” Journal of Immunology, vol. 153, no. 8, pp. 3756–3763, 1994.
- K. Hayakawa, R. R. Hardy, D. R. Parks, and L. A. Herzenberg, “The 'Ly-1 B' cell subpopulation in normal, immunodefective, and autoimmune mice,” Journal of Experimental Medicine, vol. 157, no. 1, pp. 202–218, 1983.
- L. A. Herzenberg, “B-1 cells: the lineage question revisited,” Immunological Reviews, vol. 175, pp. 9–22, 2000.
- S. Fagarasan, R. Shinkura, T. Kamata, F. Nogaki, K. Ikuta, and T. Honjo, “Mechanism of B1 cell differentiation and migration in GALT,” Current Topics in Microbiology and Immunology, vol. 252, pp. 221–229, 2000.
- H. L. Weiner, A. P. da Cunha, F. Quintana, and H. Wu, “Oral tolerance,” Immunological Reviews, vol. 241, no. 1, pp. 241–259, 2011.
- L. V. Rizzo, R. A. Morawetz, N. E. Miller-Rivero et al., “IL-4 and IL-10 are both required for the induction of oral tolerance,” Journal of Immunology, vol. 162, no. 5, pp. 2613–2622, 1999.
- L. S. Aroeira, F. Cardillo, D. A. De Albuquerque, N. M. Vaz, and J. Mengel, “Anti-IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to OVA,” Scandinavian Journal of Immunology, vol. 41, no. 4, pp. 319–323, 1995.
- A. M. C. Faria, R. Maron, S. M. Ficker, A. J. Slavin, T. Spahn, and H. L. Weiner, “Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis,” Journal of Autoimmunity, vol. 20, no. 2, pp. 135–145, 2003.
- A. M. Faria, S. M. Ficker, E. Speziali et al., “Aging affects oral tolerance induction but not its maintenance in mice,” Mechanisms of Ageing and Development, vol. 102, no. 1, pp. 67–80, 1998.
- M. C. Andrade, N. M. Vaz, and A. M. C. Faria, “Ethanol-induced colitis prevents oral tolerance induction in mice,” Brazilian Journal of Medical and Biological Research, vol. 36, no. 9, pp. 1227–1232, 2003.
- A. C. Keller, D. Mucida, E. Gomes et al., “Hierarchical suppression of asthma-like responses by mucosal tolerance,” Journal of Allergy and Clinical Immunology, vol. 117, no. 2, pp. 283–290, 2006.